Under pathological conditions, the activation of TRPV2 mediates abnormal Ca2+ influx, thus accelerating disease progression [35], which is considered as a therapeutic target for cardiovascular diseases [13, 36]. Here, TRPV2 is linked to cardiovascular disorder.